Jiangsu Tripod Preclinical Research Laboratories (Tripod) has purchased the integrated Provantis preclinical software solution suite to automate processes at its Nanjing facility.
Tripod will implement Instem’s preclinical software solution suite, Provantis 9.
Provantis will help Tripod to deliver increased efficiencies in the collection, storage and reporting of key research data and will improve service levels to sponsors.
Additionally, General Toxicology, Tables & Statistics, Protocol & Report Assembly, Dispense, Pathology, Clinical Pathology and Data Import will also be deployed.
Company officials said Tripod will also use the SaaS delivery model from Instem’s data center. Instem solutions are deployed at more sites as the Chinese preclinical market grows.
Also, Chinese CRO purchases Provantis SaaS to increase efficiency and enhance quality and automate processes at R&D facility.
“Tripod is a well-established CRO with exciting growth plans and we are honored that they have chosen Instem and Provantis to help them further improve the level of service to their sponsors and support them in their objective of becoming a world-class non-clinical research organization,” said Neil Donaldson, VP Sales Europe & Asia, Instem.
Instem has office in Shanghai which supports organizations serving the PRC through traditional on-site systems as well as through their SaaS delivery model from a secure, professionally managed data center based in Shanghai.
In March, Instem announced CiToxLAB deployed an extensive package of Instem software solutions to optimize its preclinical workflows and to support CDISC’s Standard for Exchange of Nonclinical Data (SEND).
Last year in December, Instem released Provantis 9.4 version which delivers new features and functions within the Reporting, Tables & Statistics and Pathology modules.